Skip to content

Clinical trials

Achondroplasia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Achondroplasia Country / region: Germany Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20172
20181
20192
20201
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting1
Enrolling by invitation1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ascendis Pharma A/S3
BioMarin Pharmaceutical3
Ascendis Pharma Growth Disorders A/S1
Pfizer1
QED Therapeutics, a BridgeBio company1
Universitätsklinikum Hamburg-Eppendorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Achondroplasia10
Dwarfism6
Bone Diseases3
Genetic Diseases, Inborn3
Musculoskeletal Diseases3
Osteochondrodysplasias3
Bone Diseases, Developmental2
Dwarfism, Pituitary1
Mucopolysaccharidosis IV1

Trials

Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.